Citius Pharmaceuticals to Present Mino-Lok® and COVID-related Respiratory Treatment Update at Benzinga Global Small Cap Conference on Thursday, May 13 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
UoH startup develops stem cell-based treatment for COVID-19
By IANS| Posted by Neha | Updated: 3rd May 2021 11:15 pm IST University of Hyderabad
Hyderabad: A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for COVID-19 patients.
Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities.
The treatment is associated with a significant decrease in a set of inflammatory cytokines involved in the COVID-19 ‘cytokine storm’, with significantly improved patient survival and time to recovery.
Hyd varsity startup develops stem cell-based treatment for Covid
By IANS |
Published on
Mon, May 3 2021 22:48 IST |
4 Views
University of Hyderabad to allow 2K more students on campus. Image Source: IANS News
Hyderabad, May 3 : A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for Covid patients.
Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities.
The treatment is associated with a significant decrease in a set of inflammatory cytokines involved in the Covid-19 cytokine storm , with significantly improved patient survival and time to recovery.
Express News Service
CHENNAI: When you X-ray your lungs, the colour you are most likely to see is black. In end-stage pneumonia, one of the most common COVID-19 related complications, the X-ray looks white. Why? When the Acute Respiratory Distress Syndrome (ARDS) is severe, almost the entire lung becomes white as it’s full of fluid.
For one doctor who has been doing non-stop COVID shifts since the pandemic began last January, seeing that particular image is an all too familiar foreboding, an indication of the virus claiming another victim. The doctor, who spoke to the paper on condition of anonymity, has become numb. Used to it now, unfortunately, he says.
Share:
COLOMBO (News 1st): The Director-General of Health Services confirmed that ELEVEN (11) COVID-19 deaths were reported in the country on Friday (Apr. 30), raising Sri Lanka’s COVID-19 death toll to 678.
The details of the deceased are as follows:
01. A
79-year-old female from Piliyandala. She died on 30.04.2021 on admission to a private hospital in Colombo. The cause of death is mentioned as Covid pneumonia.
02. A
76-year-old male from Dehiattakandiya. He died on 30.04.2021 while receiving treatment at Polonnaruwa General Hospital. The cause of death is mentioned as Covid pneumonia and Severe Heart Failure.
3. A
67-year-old female from Matale. She died on 29.04.2021 while receiving treatment at Matale District General Hospital. The cause of death is mentioned as Covid Pulmonary Syndrome.